Intuitive Surgical Q2 Revenue Jumps 19% to $2.89B, Adjusted EPS $2.80
ISRG is trading near its 52-week low of $378.5 (5.2% below the low) on elevated volume (2.2× avg).
Summary
Intuitive Surgical delivered a strong Q2, with revenue rising 19% to $2.89 billion and adjusted EPS of $2.80, up from $2.19 a year ago. Net income jumped to $818.1 million from $658.4 million. The company guided full-year da Vinci procedure growth of 13.5% to 15.5%, near the midpoint, and expects adjusted gross margins of 68-69%, including a 1% tariff headwind. Shares initially rose 3.43% to $402.33 in regular trading but then plunged 9.92% overnight to $362.40, suggesting the market may have been spooked by the margin outlook or broader macro concerns. This follows the 8-K filed yesterday that first reported the top-line beat and procedure growth guidance. The overnight reversal is the key focus — traders will want to understand whether the sell-off reflects disappointment with the margin guide or external factors.
At the time of this announcement, ISRG was trading at $358.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $142.5B. The 52-week trading range was $378.50 to $603.88. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: dpa-AFX.